Studii clinice pentru BPOC în Dallas, TX
12 studii pentru BPOC caută participanți în și în jurul orașului Dallas (în aproximativ 50 km). Deschideți un studiu pentru a vedea criteriile de eligibilitate și cum să contactați echipa de cercetare.
Text oficial al studiului (în engleză)
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
În curs de recrutareFaza 3
- Research Site, Dallas
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
În curs de recrutareFaza 3
- IntraCare- Site Number : 8400034, Dallas
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
În curs de recrutareFaza 3
- Texas Health Presbyterian Hospital Dallas- Site Number : 8400032, Dallas
An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema
În curs de recrutare
- University of Texas Southwestern, Dallas
A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
În curs de recrutareFaza 2
- Research Site, Dallas
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
În curs de recrutareFaza 3
- Research Site, Dallas
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
În curs de recrutareFaza 2/3
- Alina Clinical Trials, LLC., Dallas
A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
În curs de recrutareFaza 3
- GC2501 Study Site 109, Dallas
STRIVE Post-Market Registry Study
În curs de recrutareStudiu observațional
- Baylor Scott & White Research Institute, Dallas
- University of Texas Southwestern, Dallas
eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
În curs de recrutareFaza 3
- GSK Investigational Site, Dallas
Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer
În curs de recrutareStudiu observațional
- Liver Center of Texas, Dallas
Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
În curs de recrutareFaza 3
- GSK Investigational Site, Dallas
Studii pentru BPOC în alte orașe
- Philadelphia, PA23 studii
- Miami, FL18 studii
- Birmingham, AL17 studii
- Boston, MA17 studii
- Houston, TX15 studii
- Orlando, FL15 studii
- Baltimore, MD14 studii
- Chicago, IL14 studii
- Pittsburgh, PA12 studii
- New York City, NY11 studii
- Ann Arbor, MI10 studii
- Detroit, MI9 studii
Alte studii în Dallas
- Cancer de sân55 studii
- Cancer pulmonar cu celule non-pătrate52 studii
- Cancer metastatic42 studii
- Insuficiență cardiacă42 studii
- Cancer (toate tipurile)37 studii
- Cancer de prostată36 studii
- Cancer colorectal33 studii
- Obezitate30 studii
- Cancer ovarian28 studii
- Cancer de vezică urinară27 studii
- Cancer pulmonar27 studii
- Cancer endometrial24 studii
Sursă: ClinicalTrials.gov, date preluate la 3 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.